XENE Q2 2019 Earnings — Xenon Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

XENEXenon Pharmaceuticals Inc.

$5B

Q2 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$8M

Operating Income

-$11M

Net Income

-$10M

EPS (Diluted)

$-0.39

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$464,000

Balance Sheet

Total Assets

$106M

Total Liabilities

$23M

Stockholders' Equity

$83M

Cash & Equivalents

$37M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$8M	-$5M	-51.5%
Operating Income	-$11M	-$8M	-38.6%
Net Income	-$10M	-$8M	-28.3%